Studies of the association between alcohol drinking and breast cancer show a tendency towards an increase in risk for high consumption levels but yield less consistent results for low-to-moderate levels, particularly among premenopausal women. In a population-based case-control study in Germany, the authors determined the effect of alcohol consumption at low-to-moderate levels on breast cancer risk among women up to age 50 years. The study included 706 case women whose breast cancer had been newly diagnosed in 1992-1995 and 1,381 residence-and age-matched controls. In multivariate conditional logistic regression analysis, the adjusted odds ratios for breast cancer were 0.71 (95% confidence interval (CI): 0.54, 0.91) for average ethanol intake of 1-5 g/day, 0.67 (95% CI: 0.50, 0.91) for intake of 6-11 g/day, 0.73 (95% CI: 0.51, 1.05) for 12-18 g/day, 1.10 (95% CI: 0.73, 1.65) for 19-30 g/day, and 1.94 (95% CI: 1.18, 3.20) for ≥31 g/day. The association with high daily ethanol intake of ≥19 g was modified by educational level, such that odds ratios were 3.7, 1.6, and 0.7 for women with low, moderate, and high levels of education, respectively. These data suggest that low-level consumption of alcohol does not increase breast cancer risk in premenopausal women. Despite extensive research on the association between alcohol consumption and breast cancer risk, a concordance of opinions is not apparent, especially for premenopausal women. Considering that alcohol consumption is one of the few easily modifiable factors associated with breast cancer risk, while in moderate amounts it is publicly proclaimed to protect against all-cause mortality, investigations to further clarify this issue are necessary.
Despite extensive research on the association between alcohol consumption and breast cancer risk, a concordance of opinions is not apparent, especially for premenopausal women. Considering that alcohol consumption is one of the few easily modifiable factors associated with breast cancer risk, while in moderate amounts it is publicly proclaimed to protect against all-cause mortality, investigations to further clarify this issue are necessary.
Ever since a meta-analysis by Longnecker et al. (1) provided strong evidence for a dose-response relation, admittedly with a very modestly ascending slope, alcohol has been treated as a risk factor for breast cancer even at lowto-moderate daily intake levels. However, subsequently published studies based on more detailed data on lifetime consumption habits have not consistently supported this finding, particularly for low-to-moderate doses. Two cohort studies (2, 3) and three case-control studies (4-6), including two studies of women diagnosed with breast cancer before ages 49 years (2) and 36 years (4), respectively, found no association of average lifetime alcohol consumption with breast cancer risk. In another case-control study (7) of women younger than age 45 that assessed lifetime alcohol intake year by year, there was no risk association for low-to-moderate consumption but a significant increase in risk for 14 or more drinks per week. A linearly increasing risk with increasing alcohol consumption in the recent past was observed more clearly for postmenopausal women in one case-control study (8) and for premenopausal women in another (9) .
A pooled analysis of six large cohort studies (10) also did not yield results clearly consistent with those of the earlier meta-analysis (1) . The authors found current alcohol consumption at baseline to be linearly associated with an increased risk of 9 percent per 10 g per day, yet evidence was weak for premenopausal women because of large confidence intervals. Although the pooled relative risk was 1.06 (95 percent confidence interval (CI): 0.96, 1.17), the relative risk for moderate intake of 5-<15 g per day was more or less equal to 1 for four of the included studies (11) , putting any effect of low-to-moderate alcohol intake on breast cancer risk into question.
To date, effect modification has not been established consistently, although positive associations between alcohol consumption and years of education, ever use of oral contraceptives, ever use of cigarettes, and ever examination by mammography, as well as inverse associations with body mass index and age, have been reported (3, 7, (12) (13) (14) (15) (16) . However, two recent studies (17, 18) provided evidence of folate's being a plausible effect modifier of the association between alcohol and breast cancer. Adequate folate consumption appears to reduce excess risk at higher levels of alcohol intake.
There have been only a few studies of lifetime alcohol consumption and breast cancer risk in younger women (2) , and the role of alcohol consumption is still unresolved. We conducted a population-based case-control study of German women aged ≤50 years, assessing lifetime alcohol consumption in three age categories, particularly to evaluate the effect of low-to-moderate doses on breast cancer risk among premenopausal women.
MATERIALS AND METHODS
A detailed description of the population-based study design has been provided elsewhere (19) . In short, subjects eligible for participation were German-speaking women with no former history of breast cancer who resided in one of two geographic areas in southern Germany. We attempted to recruit all patients who were under 51 years of age at the time of diagnosis of incident in-situ or invasive breast cancer. We compiled cases diagnosed between January 1, 1992, and December 31, 1995, in the Rhein-Neckar-Odenwald study region and between January 1, 1993, and December 31, 1995, in the Freiburg study region, by surveying 38 hospitals that serve the populations of these two regions. Patients were identified through frequent monitoring of hospital admissions, surgery schedules, and pathology records. Controls were selected from random lists of residents supplied by the population registries. For every recruited patient, two controls matched according to exact age and study region were immediately contacted by letter.
There were 1,020 eligible patients, of whom 1,005 were alive when identified. Of these living case subjects, 706 (70.2 percent) completed the study questionnaire. Among the 2,257 eligible controls, 1,381 (61.2 percent) participated.
The participants completed a self-administered questionnaire pertaining to demographic, reproductive, menstrual, and anthropometric factors, family history of cancer, hormone replacement therapy, oral contraceptive use, medical history, smoking, and alcohol consumption. If not otherwise specified, all information was truncated at the reference date, which was the date of diagnosis for cases and the date of completion of the questionnaire for controls. Median time between diagnosis and interview was 2 months. Menopausal status was assigned according to the woman's reported status 6 months before the reference date. For women with previous hysterectomy not accompanied by bilateral oophorectomy, menopausal status was not identifiable and was classified as unknown.
Average alcohol consumption was assessed for three time periods: ages 15-20 years, ages 20-30 years, and ages 30-50 years. Neither ages at which drinking began and ended nor information on intermittent periods of abstention was elicited. For five different types of alcoholic beverages-beer, wine, aperitifs, liqueur, and spirits-participants provided information on quantities consumed in either liters or centiliters and designated their frequency of consumption as daily, weekly, or monthly.
We calculated amounts of ethanol ingested by assuming 3.5 g of ethanol per 100 ml of beer, 10 g of ethanol per 100 ml of wine, 16 g of ethanol per 100 ml of aperitifs, 22 g of ethanol per 100 ml of liqueur, and 35 g of ethanol per 100 ml of spirits. A 12-ounce serving of beer contains approximately 12 g of ethanol; 4 ounces of wine contains approximately 12 g, 1.5 ounces of aperitifs about 7 g, 1.5 ounces of liqueur about 10 g, and 1.5 ounces of spirits about 15 g. Ethanol consumption for the latter three beverages was calculated separately and then combined into one category, "hard liquor." Average ethanol consumption was calculated by multiplying daily average alcohol intake in each of the three time periods by the number of years in each period (until the woman reached the reference age, where appropriate), summing over the three time periods, and dividing by the total number of years.
We computed odds ratios and 95 percent confidence limits using multivariate conditional logistic regression analysis. Estimates were produced using the PHREG procedure in the statistical software package SAS (release 6.12; SAS Institute, Inc., Cary, North Carolina). We performed the analyses with stratification for age in 1-year intervals in order to optimize age adjustment. We conducted doseresponse analysis using the method of fractional polynomials (20) . This method is useful for examining a possibly nonmonotonic relation between the risk factor and disease risk. The covariable x enters the logistic regression model via a set of defined transformations as a polynomial. To allow for a nonmonotonic relation, the polynomial must be of degree 2. The function that best fits the data is then selected. We assessed the association between breast cancer and the different types of beverages with a model including categorized intake of all beverages simultaneously.
In each analysis, we compared alcohol consumers of different intake levels with nondrinkers, defined as those who ingested less than 0.5 g of ethanol per day. Repeat analyses using total lifetime abstainers as the reference group produced essentially the same results; therefore, those data are not reported.
The following terms were included in the multivariate analyses: number of full-term pregnancies and total number of months of breastfeeding, as continuous variables; education (classified as low, intermediate, or high according to type of schooling completed); family history of breast cancer (breast cancer in a mother or sister); and menopausal status (postmenopausal, premenopausal, or unknown). Other factors, such as body mass index, oral contraceptive use, age at first birth, age at menarche, smoking status, study region, and marital status, did not materially alter the estimates and therefore were not included in the statistical models.
The interaction of alcohol consumption with other covariables was investigated using the difference between deviances of the models with and without the interaction terms. Table 1 depicts some relevant characteristics of the study population. The mean age of cases was 42.5 years, and that of controls was 42.6 years. Ninety-six percent of the cases and controls were between ages 30 and 50 years; i.e., they fell into the highest age category of alcohol assessment.
RESULTS
Ninety-three percent of the patients had invasive tumors, and 7 percent had in situ tumors. With respect to other risk factors and potential confounders, controls had more fullterm pregnancies, had longer durations of breastfeeding, and less often had a family history of breast cancer. Data on age at menarche, years of oral contraceptive use, age at first birth, educational level, and smoking status were distributed similarly between cases and controls.
Possible associations between potential risk factors and confounders and alcohol consumption were examined descriptively for four different levels of alcohol intake in cases and controls (table 2) . Among controls, alcohol drinkers tended to be more highly educated, slimmer, ever smokers, ever users of oral contraceptives, and nulliparous and to have ever had a mammogram 2 years before the reference date. In the highest alcohol intake group, ≥19 g/day, more controls were well educated (40 percent of controls vs. 21.4 percent of cases). The interaction of alcohol consumption with education is discussed in more detail below. Breastfeeding practices differed between cases and controls in the higher intake groups of 12-18 g/day and ≥19 g/day, with approximately 45 percent of controls and 57 percent of cases having never breastfed. There was no significant interaction between breastfeeding and alcohol consumption.
More controls than cases reported drinking alcohol (82.7 percent vs. 78.3 percent; table 3). However, mean daily intake was higher for cases (11.1 g (standard deviation 14.5) among drinkers only) than for controls (8.4 g (standard deviation 9.0) among drinkers only).
Our data indicated a decrease in risk of approximately 30 percent for alcohol consumption levels of 1-5, 6-11, and 12-18 g/day (table 3) . However, for intake of ≥19 g/day, the odds ratio was 1.35 (95 percent CI: 0.96, 1.92) (data not shown). We separated the highest intake group into two groups, 19-30 g/day and ≥31 g/day, to further explore a category containing the heaviest drinkers. While alcohol consumption of 19-30 g/day yielded a weak risk elevation of 10 percent, daily consumption of ≥31 g was associated with a significant odds ratio of 1.94 (95 percent CI: 1.18, 3.20; table 3). Dose-response analysis yielded the fractional polynomial log(x ϩ 1) ϩ as the best model. The resulting function, OR(x) ϭ exp(-1.26 log(x ϩ 1) ϩ 0.83 ), is displayed in figure 1 .
We investigated whether the effects of alcohol were timedependent (table 4). Because of the age distribution of our study participants, current intake was reflected by intake between ages 30 and 50 years, and prior intake closely resembled intake between ages 20 and 30 years. At all ages, more controls than cases consumed alcohol overall; however, the proportion of cases with a daily intake of ≥19 g was always higher than that of controls. The odds ratios in each age category were similar to the overall risk association found, with the exception of an odds ratio of 1.00 (95 per1x 1x cent CI: 0.73, 1.37) for daily consumption of ≥19 g between ages 30 and 50 years. Overall, it appears that the doseresponse function is a J-shaped curve independent of the age at which alcohol consumption is considered.
Cases and controls showed similar beverage preferences; however, they differed in terms of average daily amounts of specific beverages consumed (table 5) . Intakes of hard liquor differed only slightly, with 18.6 percent of cases and 17.2 percent of controls being consumers. The same proportions of cases and controls, approximately 61 percent, did not drink beer. The difference lay in the amount consumed: The odds ratios were elevated for 6-11 and ≥12 g/day of ethanol from beer consumption.
Wine was the preferred drink among participants, and therefore it mirrored average total alcohol consumption. Average daily wine consumption, categorized as in table 3, yielded odds ratios similar to those for average total alcohol consumption: 0.68 for 1-5 g of alcohol from wine daily, 0.73 for 6-11 g/day, 0.84 for 12-18 g/day, and 1.17 for ≥19 g/day (table 5). The odds ratio for the highest wine intake group was somewhat smaller in comparison with total alcohol consumption.
We tested for an interaction between alcohol consumption and educational level, combining the two lower alcohol consumption categories as 1-11 g/day, thereby adding six multiplicative interaction terms. We found the interaction term for the highest level of alcohol intake (≥19 g/day) and a high educational level to be significant (p ϭ 0.01). The estimates of the reduced interaction model, which included only two interaction terms for the highest level of alcohol intake and intermediate or high educational level, did not significantly differ from those of the full model; therefore, it was used to calculate odds ratio estimates for alcohol consumption according to educational level.
Odds ratios for differing levels of alcohol consumption by educational level, in reference to the nondrinking group, are shown in Odds ratios for the other alcohol consumption categories were unchanged by education status.
DISCUSSION
In this study, we found a reduced breast cancer risk of approximately 30 percent for low-to-moderate alcohol consumption levels of 1-5, 6-11, and 12-18 g/day. However, we observed an odds ratio around unity for intake of 19-30 g/day and a significantly increased risk for ≥31 g/day. Several other investigators have also found a reduced risk or no association for low-to-moderate alcohol intakes under a certain threshold, above which risk was increased (7, 16, (21) (22) (23) (24) (25) . The threshold ethanol level varies from 15 g/day to 50 g/day across studies, partly because of arbitrarily chosen cutpoints for intake categories. The continuous doseresponse curve shown in figure 1 , which fitted the odds ratios of the categories very well, represents a good approach to avoiding setting arbitrary thresholds.
Other investigators have found no association between alcohol consumption and breast cancer risk overall (2-6), and a recent case-control study (26) found no association among premenopausal women. A pooled analysis of six cohort studies (10) including 322,647 women and 4,335 breast cancer cases concluded that alcohol consumption is associated with a linear increase in breast cancer incidence. However, the estimated pooled risks for low-to-moderate intakes of 0-1.5, 1.5-5, and 5-15 g/day were near unity and not statistically significant. The lack of association for these low-to-moderate intake levels is apparent for the individual studies, with four of the included studies showing a relative risk close to 1 for moderate intakes of 5-<15 g/day. A recent review article on alcohol intake and late-stage promotion of breast cancer deduced that the epidemiologic association between alcohol consumption and increased breast cancer risk is more prominent among postmenopausal women than among premenopausal women and that a significant increase in risk is associated with intakes of >30 g/day over a period of years (24) . Our study had relatively small proportions of participants who consumed more than 19 g of alcohol per day: 14.5 percent of the cases and 8.7 percent of the controls. Our odds ratio of 1.35 for this group, albeit not statistically significant, is of the same order of magnitude as estimates from other studies which have found an effect of high alcohol intake on breast cancer risk (7, 9, 15, 22, (27) (28) (29) . Risk elevations of approximately twofold, comparable to that found in this study for consumption of ≥31 g/day, were reported by several investigators (7, 8, 15, 23, 28) . In accordance with this study, some researchers have reported a significantly increased breast cancer risk only for alcohol intakes varying between 24 and 40 g/day (7, 9, 10, 21, 27) . Some other studies may not have been able to find an association because the numbers of women consuming higher amounts of alcohol were too small. For assessment of high levels of intake, it seems important to consider sporadic heavy drinking using questionnaires with graduated frequency measures (30) . This should be considered in future studies involving alcohol assessment.
The variance in the alcohol intake levels above which breast cancer risk is increased may be accounted for by small numbers of women at high intake levels, as well as by arbitrary categorization, differing consumption patterns between countries, and differing methods of data assessment. Valid associations between alcohol intake and disease are identifiable; however, the strength of sensible limits of acceptable alcohol intake depends to a great extent on the assessment methods used (31). Temporal aspects of alcohol consumption have not consistently been shown to be relevant (1, 32) . Recent results (7) suggested that alcohol may be more of a tumor enhancer and promoter than a tumor initiator. We did not observe a significant difference in breast cancer risk associated with intake in different time periods. However, because of the large age category of 30-50 years used in our study and the unknown exact ages at which drinking ended, we may not have been able to differentiate alcohol consumption at late stages of breast cancer adequately.
We found that education status modified the effect of alcohol intake on breast cancer risk. Other studies have observed that higher socioeconomic status or a higher level of education is associated with higher alcohol intake (3, 7, 12-16), but none have reported a significant interaction. Striking in our data was the significantly increased risk for the consumption category of ≥19 g/day, with odds ratios of 3.7 for women with low education and 1.6 for somewhat better educated women, as compared with no change in risk for highly educated women across all levels of alcohol intake.
Educational level may be a surrogate for an effect modifier or confounder that is not yet clearly established. Two recent studies suggested the possibility of a breast cancer (17, 18) . In Germany, folate intake has been found to be positively associated with years of education (33, 34) . Our findings are plausible if high folate consumption among better educated women alleviates the effect of alcohol on breast cancer risk. Overall, a better diet according to currently recommended guidelines may lessen deleterious effects of alcohol, since health effects may depend on overall dietary patterns and not only on single nutrients or food groups (35) . Different types of alcoholic beverages have been inconsistently associated with breast cancer risk and have been postulated not to have a differential effect (1, 3) . We believe this discussion is still open, since preferences for beverage types vary considerably across subpopulations, rendering comparisons extremely difficult. It has been suggested that detrimental associations with particular types of beverages are found for the beverages most commonly consumed and merely reflect ethanol intake, implying that ethanol (or its metabolites) is the causal agent (5). On the contrary, we found that risk was increased at a lower consumption level for beer than for wine, although wine was the preferred drink among our participants.
We were able to compare our data on alcohol consumption with alcohol data from the Heidelberg EPIC (European Prospective Investigation in Cancer) cohort, which comprises 13,597 women and shows very similar consumption patterns (36) . The mean average daily alcohol consumption of EPIC subjects of comparable age is somewhat higher than in our study. This may be due to the higher socioeconomic status of the cohort (37), since alcohol intake has been found to be more common among persons of higher socioeconomic status in other studies (12) . In another large prevalence study in the German population, comparable alcohol consumption patterns were observed, as well as our finding that proportions of women who consume moderate to high amounts are greater among wine drinkers than among beer drinkers (38) .
These corroborating findings indicate that the controls in our study are representative of the female German population. However, selection bias could explain the finding of a significant protective effect at low levels of alcohol consumption, if the patients who participated were less likely to drink alcohol.
Data collected on alcohol consumption in the distant past appear reliable (39) , and recall bias seems to play only a modest role in reported intake (40) . Nonetheless, recall bias cannot be ruled out, since the self-reported data were collected after diagnosis among cases. Recall bias may have led to the smaller risk estimate for the highest intake category at ages 30-50 years, compared with intake in the other two age categories, as well as the low risk estimates for lower lifetime consumption levels, if cases tended to underreport their alcohol intake. The assessed categories were fairly large, forcing women to average their alcohol consumption over 5-, 10-, and 20-year intervals, and did not allow for intermittent abstention phases such as pregnancies or breastfeeding periods. Information on the date of initiation or cessation of drinking was not specifically collected, but initiation date was set at the lower cutpoint of the first age period for which drinking was reported, and cessation date analogously was set at the higher cutpoint of the last age period for which drinking was reported. However, because the data were treated in the same manner, this should not have led to differential assessment of alcohol consumption in cases and controls.
The biologic mechanisms of alcohol's effects on breast cancer etiology are widely discussed but not proven in detail. Effects on hormone metabolism have been shown, with higher estradiol and estrone levels being described in women with chronic alcohol intake (41) . Recent developments suggest that insulin-like growth factors may mediate the effect of alcohol on breast cancer risk by acting as estrogen synergists and apoptosis suppressants (42) . Another model suggests the involvement of alcohol-derived reactive oxygen species in inducing DNA modifications and carcinogenesis (43) .
Although several plausible mechanisms exist which may link chronic alcohol consumption to breast cancer in a doseresponse fashion, the critical effects on cancer and other outcomes may have thresholds. Thus, the absence of adverse effects on breast cancer risk for low-to-moderate alcohol consumption in our study is plausible.
The unexpected finding of a significant protective effect of alcohol consumption at low levels seems to pertain primarily to wine. Wine, particularly red wine, contains a range of polyphenols with antioxidant effects. One of these compounds is resveratrol, a triphenolic stilbene found in grapes and other plants which has been considered responsible for the beneficial effects of red wine consumption on coronary heart disease risk. Recent studies revealed that resveratrol can inhibit each step of multistage carcinogenesis (44) and that it has an antiproliferative effect on human breast epithelial cells (45) , possibly because of the inhibiting properties of the enzymes cyclooxygenase 1 and 2 (45-47) and cytochrome P-450 (48, 49) .
In general, it is possible that at low-to-moderate levels of wine consumption, the beneficial role of polyphenols may counteract the cancer-promoting function of the alcoholic component in wine and account for the results presented here. For higher levels of regular alcohol intake, the balance may shift to outweigh the beneficial effects. However, we cannot exclude the possibility that this may be a chance finding. Individual genetic variation in alcohol metabolism, as has been observed in other studies (50, 51) , may also partly explain our results. The risk : benefit ratio of alcohol consumption appears to be very complex, because of the multilevel interactions of ethanol, wine phytochemicals, carcinogens, dietary factors, and genetic variations in metabolizing enzymes.
Public health recommendations on alcohol consumption must take numerous factors into consideration. Most important is the established association of less than one drink per day with the lowest all-cause mortality for women (12) . In our view, another crucial facet of this discussion is that low intake of alcohol does not appear to raise premenopausal breast cancer risk.
